A Study of the Gene Therapy

Are you guys aware of this research? Posting for informational purposes only. Not affiliated with this clinical trial:

A Study of the Gene Therapy CGF166 in Patients with Severe-to-Profound Hearing Loss

                                                                                                                                                         A three-part, multicenter, open label, single dose  study of the gene therapy CGF166 in patients with severe-to-profound  hearing loss. CGF166 is recombinant adenovirus 5 (Ad5) vector containing  the human Atonal transcription factor (Hath1) cDNA. The purpose of the  study is to evaluate the safety, tolerability, and the potential ability  of CGF166 delivered through intra-labyrinthine infusion to improve  hearing and vestibular function.